TCL Archive Center Directors Solidly opposed To Core grant changes, Ask Upton, NCAB To Find Other Solutions November 11, 1977
TCL Archive Cooperative Groups: Insurers Agree To Cover Patient Care Costs In Group Trials September 26, 1997
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
